EVO Relative Valuation
EVO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, EVO is overvalued; if below, it's undervalued.
Historical Valuation
Evotec SE (EVO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.41 is considered Undervalued compared with the five-year average of 467.94. The fair price of Evotec SE (EVO) is between 842.74 to 857.85 according to relative valuation methord. Compared to the current price of 4.18 USD , Evotec SE is Undervalued By 99.5%.
Relative Value
Fair Zone
842.74-857.85
Current Price：4.18
99.5%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.70
P/B
Median3y
2.10
Median5y
3.83
-4.80
FCF Yield
Median3y
-6.87
Median5y
-4.23
Competitors Valuation Multiple
The average P/S ratio for EVO's competitors is 1228.39, providing a benchmark for relative valuation. Evotec SE Corp (EVO) exhibits a P/S ratio of 1.41, which is -99.89% above the industry average. Given its robust revenue growth of -7.23%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Evotec SE (EVO) currently overvalued or undervalued?
What is Evotec SE (EVO) fair value?
How does EVO's valuation metrics compare to the industry average?
What is the current P/B ratio for Evotec SE (EVO) as of Jul 08 2025?
What is the current FCF Yield for Evotec SE (EVO) as of Jul 08 2025?
What is the current Forward P/E ratio for Evotec SE (EVO) as of Jul 08 2025?